Use of a slow-release intravitreal clindamycin implant for the management of ocular toxoplasmosis
Abstract Purpose To report the first patient with ocular toxoplasmosis treated with a slow-release biodegradable intravitreal clindamycin implant. Observations A 39-year-old human immunodeficiency virus (HIV)-positive woman with recurrent toxoplasmic retinochoroiditis…